Interdigitating and follicular dendritic cell sarcomas: a SEER analysis.

Area of Science:

• Oncology
• Pathology

Background:

• Follicular dendritic cell sarcoma (FDCS) and interdigitating dendritic cell sarcoma (IDCS) are rare neoplasms originating from dendritic cells.
• The rarity of these conditions makes optimal management strategies unclear.

Purpose of the Study:

• To analyze and compare the management and outcomes of FDCS and IDCS using population-based data.
• To identify prognostic factors influencing survival in patients diagnosed with FDCS or IDCS.

Main Methods:

• Retrospective review of the Surveillance, Epidemiology, and End Results (SEER) database.
• Identification of 54 FDCS and 20 IDCS cases diagnosed between 2001 and 2008.
• Analysis of treatment modalities (surgery, radiation) and survival data.

Main Results:

• Follicular dendritic cell sarcoma (FDCS) patients demonstrated significantly better overall survival compared to interdigitating dendritic cell sarcoma (IDCS) patients.
• Localized disease was observed in 61% of FDCS and 55% of IDCS patients, with surgical resection being a common treatment for localized FDCS (94%) and IDCS (55%).
• Localized IDCS patients had significantly improved survival (2-year OS 72%) compared to distant IDCS (2-year OS 33%).

Conclusions:

• Localized FDCS and IDCS are often managed similarly to soft tissue sarcomas, with primary surgical resection +/- radiation.
• The specific roles of chemotherapy and radiation therapy in the management of these rare sarcomas require further investigation.
• The SEER database lacked chemotherapy data, highlighting a limitation in assessing its impact.